US Dermatological Therapeutics Market is at around $16.88 Bn in 2023 and is projected to reach $26.40 Bn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The development of innovative therapies, the growing trend of cosmetic dermatology, and the increasing prevalence of skin conditions are driving the growth of the market. The market is dominated by key players like Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.
US Dermatological Therapeutics Market is at around $16.88 Bn in 2023 and is projected to reach $26.40 Bn in 2030, exhibiting a CAGR of 6.6% during the forecast period.
Dermatological Therapeutics is dedicated to the identification and management of skin conditions. It includes a broad spectrum of therapeutic and aesthetic procedures intended to treat several types of dermatological disorders, including tumors, inflammatory diseases, and infections. Surgical procedures, laser therapy, topical or systemic drugs, and other cutting-edge methods can all be part of dermatological therapeutics. Restoring or maintaining the skin's health and look while taking care of aesthetic and medical issues is the aim. Dermatologists are experts at using evidence-based treatments to give their patients the best possible results.
The US market for dermatological therapies is well-established and experiencing growth due to increased consumer demand for advanced skin-related therapies. One in four Americans, or 84.5 Mn people, suffered from a skin condition. Its dynamic and developing nature is attributed to several factors, including technological improvements, an aging population, and their emphasis on customized dermatological treatments. Leading companies keep coming up with innovative concepts and providing a variety of product lines to treat a broad spectrum of skin disorders.
Revenues from the dermatological treatments market have increased dramatically, reaching $40.94 Bn worldwide in 2023. Revolutionizing the industry, this growth is driven by cost-effective production techniques and transformational technologies. The dynamic confluence of innovation, accessibility, and financial support is reflected in the changing landscape, which has shaped the dermatological treatment market into a thriving and resilient domain.
Currently undergoing Phase 3 trials for moderate-to-severe plaque psoriasis, Amgen's AMG 4375, an IL-17A inhibitor, has demonstrated encouraging efficacy in removing skin lesions. Phase 2 trials for hidradenitis suppurativa, a chronic inflammatory skin disorder, are being conducted on AMG 9557, another IL-17A inhibitor.
Market Growth Drivers:
Development of Innovative Therapies: New and more effective treatments for a range of skin problems are being developed as a result of ongoing breakthroughs in pharmaceutical and medical technologies. This promotes income generation and market expansion.
Growing Trend of Cosmetic Dermatology: With the expanding trend, procedures like Botox, dermal fillers, and laser treatments have increased demand for cosmetic dermatological products and services, thus leading to the growth of the market.
High Prevalence Skin Conditions: Millions of people in the US suffer from a high prevalence of chronic skin disorders like psoriasis, eczema, and acne. The market is growing because of the continuous need for therapy.
Market Restraints:
Strict FDA Approval Procedure: The FDA's stringent safety and efficacy requirements make it a costly and time-consuming process to bring new treatments to market. This may impede smaller businesses' access to the market and deter investment in novel medications.
Post-marketing Surveillance: Continued safety inspections and possible risk-benefit analyses may result in the withdrawal or restriction of a product, which would affect sales and create uncertainty in the market.
Availability of Generic Drugs: When branded medications lose their patent exclusivity, less expensive generic substitutes become available, which drives down prices and lowers profits for the original producers.
The US regulatory body in charge of policing dermatological drugs is the Food and Drug Administration (FDA). The FDA ensures that new drugs are safe and effective by evaluating and approving them. For the majority of novel therapeutic drugs and biologics, the development process consists of three primary stages: pre-clinical, clinical, and FDA review. The process of obtaining a license for a drug is fraught with difficulties, including stringent restrictions, lengthy and costly development timeframes, and difficulties in clinical trials.
Key Players:
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type
By Disease
By Drug Class
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?